Endocannabinoid interference blocks post-global cerebral ischemia depression through prefrontal cortico-amygdala projections
- 24 November 2024
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 50 (7) , 1063-1074
Abstract
Up to 45% of patients surviving from transient global cerebral ischemia (GCI) after cardiac arrest develop post-global cerebral ischemia depression (PGCID), but how to treat PGCID is clinically unknown. Here we find that cannabinoid type-1 receptor (CB1R) antagonists, CB1R knockout and endocannabinoid (eCB) synthesis inhibition block acute stress-induced PGCID. Application of acute stress to GCI mice increases CB1R activity from ventromedial prefrontal cortical (vmPFC) terminals synapsing with the basolateral amygdala (BLA) neurons, indicating the involvement of increased vmPFC-BLA synaptic eCB signaling in PGCID induction. This idea is supported by findings that optogenetic activation of CB1Rs in vmPFC-BLA projections mimics stress effects to induce PGCID, which is blocked by knock-down of eCB biosynthesis enzyme genes in vmPFC-BLA synapses. Interestingly, GCI mice show decreased mRNA expression of eCB degradation enzymes in vmPFCs without significant changes on mRNA expression of eCB biosynthesis and degradation enzymes in BLA cells. Thus, over-expression of eCB degradation enzymes in vmPFC cells innervating BLA neurons or activation of vmPFC-BLA projections blocks stress effects to induce PGCID. Our findings suggest that decreased eCB degradation and subsequent stress-increased eCB signaling in vmPFC-BLA circuits participate in the mechanism of PGCID, which can be treated clinically by eCB signaling interference systemically or in vmPFC-BLA circuits.Keywords
Funding Information
- National Natural Science Foundation of China (32371187, 32000788, 81830035, 82090033)
- Natural Science Foundation of Shandong Province (ZR2024MH063, ZR2019ZD35)
- Ministry of Science and Technology of the People's Republic of China (2021ZD0203002)
This publication has 48 references indexed in Scilit:
- Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in miceBehavioural Brain Research, 2007
- ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNSAnnual Review of Neuroscience, 2006
- Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim testEuropean Neuropsychopharmacology, 2005
- Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effectsJournal of Clinical Investigation, 2005
- Contributions of the Amygdala to Emotion Processing: From Animal Models to Human BehaviorNeuron, 2005
- The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusionPharmacology Biochemistry and Behavior, 2004
- Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 ReceptorsJournal of Neuroscience, 2004
- Sudden Cardiac Death in the United States, 1989 to 1998Circulation, 2001
- Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal InterneuronsThe Journal of Neuroscience, 1999
- Neuropsychological Sequelae of Cardiac ArrestJAMA, 1993